Novo Nordisk Says Wegovy Weight-Loss Pill Matches Shot as it Eyes Landmark Approval

The company’s experimental daily pill helped patients lose an average 16.6% of their weight, according to late-stage trial, and it could be approved in the U.S. by the end of the year.